Cocrystal Pharma, Inc.
Clinical-stage biotech developing antiviral drugs for serious and chronic viral diseases.
COCP | US
Overview
Corporate Details
- ISIN(s):
- US19188J4094
- LEI:
- Country:
- United States of America
- Address:
- 19805 N. CREEK PARKWAY, 98011 BOTHELL
- Website:
- https://www.cocrystalpharma.com/
- Sector:
- Manufacturing
Description
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company that discovers and develops novel antiviral therapeutics for serious and chronic viral diseases. The company utilizes proprietary structure-based drug design technologies to create antiviral drugs that target the viral replication process. Its development pipeline includes programs targeting influenza, SARS-CoV-2 (COVID-19), norovirus, and hepatitis C. Key candidates in its pipeline include CC-42344, a PB2 inhibitor for influenza A in Phase 2 clinical trials, and CDI-988, an oral pan-viral protease inhibitor for norovirus and coronaviruses that has entered Phase 1 trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cocrystal Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cocrystal Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cocrystal Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
